These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21485682)

  • 1. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictive versus unrestrictive use of sugammadex for reversal of rocuronium: a decision analysis.
    Lin CJ; Eikermann M; Mahajan A; Smith KJ
    Br J Anaesth; 2024 Feb; 132(2):415-417. PubMed ID: 38104004
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurarisation after sugammadex in children: review of case reports and recommendations.
    Salaün JP; Décary E; Veyckemans F
    Br J Anaesth; 2024 Feb; 132(2):410-414. PubMed ID: 38170632
    [No Abstract]   [Full Text] [Related]  

  • 4. Unraveling the molecular dynamics of sugammadex-rocuronium complexation: A blueprint for cyclodextrin drug design.
    Anderson A; García-Fandiño R; Piñeiro Á; O'Connor MS
    Carbohydr Polym; 2024 Jun; 334():122018. PubMed ID: 38553217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sugammadex for neuromuscular blockade reversal on a dog with myasthenia gravis undergoing thymoma resection.
    Araos J; Martin-Flores M
    Vet Anaesth Analg; 2024; 51(3):310-312. PubMed ID: 38561309
    [No Abstract]   [Full Text] [Related]  

  • 6. Sugammadex dose in infants.
    Cortínez LI; Anderson BJ
    Paediatr Anaesth; 2024 Jan; 34(1):5-6. PubMed ID: 37807656
    [No Abstract]   [Full Text] [Related]  

  • 7. A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU.
    Bologheanu R; Lichtenegger P; Maleczek M; Laxar D; Schaden E; Kimberger O
    Sci Rep; 2022 Jan; 12(1):897. PubMed ID: 35042888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaesthesia and orphan disease: airway and anaesthetic management in Huntington's disease.
    Nguyen PT; Meeks D; Liotiri D
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.
    Schaller SJ; Fink H
    Core Evid; 2013; 8():57-67. PubMed ID: 24098155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex and neuromuscular disease: a systematic review with assessment of reporting quality and content validity.
    Schneider A; Tramèr MR; Keli-Barcelos G; Elia N
    Br J Anaesth; 2024 Jul; ():. PubMed ID: 38997841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on 'Potential interaction between exogenous anabolic steroids and sugammadex: failed reversal of rocuronium in a patient taking testosterone and trestolone acetate'.
    Stanley S; Hansel J
    Anaesth Rep; 2024; 12(1):e12280. PubMed ID: 38250051
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal Of Neuro-Muscular-Blockade in End-Stage Renal Disease: Can One Study Build Evidence for "ROME?".
    Nhan HN; Ramarapu S; de Armendi AJ; Butt AL
    Anesth Analg; 2024 Aug; 139(2):e9. PubMed ID: 39008868
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpoliomyelitis Syndrome and Reversal With Sugammadex: A Case Report.
    Marshall VE; Storey JS; Clayton BA; Zander EH
    AANA J; 2020 Oct; 88(5):380-382. PubMed ID: 32990207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidence for the use of sugammadex in children.
    Tobias JD
    Paediatr Anaesth; 2017 Feb; 27(2):118-125. PubMed ID: 27859917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex usage in a patient with dermatomyositis.
    Kendigelen P; Tutuncu AC; Ashyralyyeva G; Hamamcioglu EA; Kaya G
    J Clin Anesth; 2015 Aug; 27(5):438-9. PubMed ID: 25910531
    [No Abstract]   [Full Text] [Related]  

  • 18. Sugammadex in a patient with Sjogren's syndrome and polymyositis.
    Carron M; Ieppariello G; Ori C
    Br J Anaesth; 2013 Dec; 111(6):1034-5. PubMed ID: 24233320
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis.
    Jakubiak J; Gaszyński T; Gaszyński W
    Anaesthesiol Intensive Ther; 2012; 44(1):28-30. PubMed ID: 23801510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.